MedPath

A randomised clinical trial comparing safety and efficacy of topical preparations for the eradication of methicillin resistant staphylococcus aureus (MRSA) compared with a novel preparation based on a specific blend of essential oils in surgical oncology patients. - Eradication of MRSA in surgical patients using essential oils

Phase 1
Conditions
Colonisation with methicillin resistant Staphylococcus Aureus (MRSA)
Registration Number
EUCTR2005-002698-65-GB
Lead Sponsor
Christie Hospital NHS Trust
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Recruiting
Sex
Not specified
Target Recruitment
110
Inclusion Criteria

•(Pilot Study) Surgical Patients aged 16 years or over, colonised with MRSA who are due to receive surgery at the Christie Hospital NHS Trust requiring at least an overnight stay.
•(Main Study) All patients 16 years or over identified as being MRSA+ who are due to receive surgery at the Christie Hospital NHS Trust requiring at least an overnight stay.
Are the trial subjects under 18? yes
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

•Patients on relevant topical / systemic antibiotics
•Patients with a history of allergy or sensitivity to relevant compounds.
•(Pilot Study) Patients who have any signs of acute skin reaction from recent treatment.
•(Pilot Study) Patients having any adjunctive radiotherapy or chemotherapy six weeks before or during the course of the trial.

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath